CONCLUSION
There are a range of alternative inhalers available that people currently using Vectura products could switch to if it this becomes necessary because of a tobacco industry takeeover. A consideration based on beneficence, non-maleficence, autonomy, and distributive justice demonstrates strong ethical reasons to support this switch, which can be achieved without any significant risk to patient outcomes.